These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15233810)

  • 1. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome.
    Veronese FV; Noronha IL; Manfro RC; Edelweiss MI; Goldberg J; Gonçalves LF
    Clin Transplant; 2004 Aug; 18(4):357-64. PubMed ID: 15233810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
    Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
    Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers in subclinical acute rejection of renal transplants.
    Aquino Dias EC; Veronese FJ; Santos Gonçalves LF; Manfro RC
    Clin Transplant; 2004 Jun; 18(3):281-7. PubMed ID: 15142049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome.
    Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N
    Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
    Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW
    J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.
    Yoon HE; Kim SH; Kim JY; Oh EJ; Park SC; Choi BS; Choi YJ; Moon IS; Kim YS; Yang CW
    Clin Transplant; 2009; 23(6):812-8. PubMed ID: 19191803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques.
    Yehia M; Matheson PJ; Merrilees MJ; Beaumont BW; Pilmore HL
    Nephrology (Carlton); 2006 Jun; 11(3):261-6. PubMed ID: 16756643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol biopsies after kidney transplantation.
    Böhmig GA; Regele H; Hörl WH
    Transpl Int; 2005 Feb; 18(2):131-9. PubMed ID: 15691264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we have to treat subclinical rejections in early protocol renal allograft biopsies?
    Masin-Spasovska J; Spasovski G; Dzikova S; Petrusevska G; Lekovski Lj; Ivanovski N; Popov Z
    Transplant Proc; 2007 Oct; 39(8):2550-3. PubMed ID: 17954170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection.
    Mengel M; Mueller I; Behrend M; von Wasielewski R; Radermacher J; Schwarz A; Haller H; Kreipe H
    Transpl Int; 2004 Jul; 17(6):293-300. PubMed ID: 15221125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential predictive markers in protocol biopsies for premature renal graft loss.
    Matl I; Hribova P; Honsova E; Brabcova I; Viklicky O
    Kidney Blood Press Res; 2010; 33(1):7-14. PubMed ID: 20090361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.
    Vallejos A; Alperovich G; Moreso F; Cañas C; de Lama ME; Gomà M; Fulladosa X; Carrera M; Hueso M; Grinyó JM; Serón D
    Nephrol Dial Transplant; 2005 Nov; 20(11):2511-6. PubMed ID: 16077142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into subclinical rejection.
    Rush D;
    Transplant Proc; 2004 Mar; 36(2 Suppl):71S-73S. PubMed ID: 15041310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Banff borderline acute rejection among renal allograft recipients.
    Matoza JR; Danguilan RA; Chicano S
    Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.